22 September 2006
Ethical and Social Aspects of Transplantation Medicine in Poland and Worldwide
Wojciech RowinskiAnn Transplant 2006; 11(3): 31-37 :: ID: 497002
Abstract
New medical technologies are products of human mind and the result of development in the field of diagnostic techniques, pharmacotherapy and biotechnology. Transplantation medicine, which is also a new medical technology, differs from the others in that it requires a living organ obtained from a dead person or a living donor. Development of market economy and globalization have made the new technologies available almost in every country. Along with them some expectations have come up among the societies, that what is possible – soon will be available. This applies also to transplantation medicine. However, its availability is restricted by flawed or misinterpreted regulations, ethical and social barriers, and financial potential. Transplantation process depends enormously on economical conditions and attitude of both the society, and the medical profession.
Keywords: Ethics, Social Barriers, economy, globalization, Transplantation
In Press
Original article
Common Versus External Iliac Arterial Anastomosis in Kidney Transplantation: A Bicentric Retrospective Anal...Ann Transplant In Press; DOI: 10.12659/AOT.953269
Original article
Protective Effects of Quercetin and Sucrose on Cold Preservation Injury in Porcine Kidneys Donated After Ca...Ann Transplant In Press; DOI: 10.12659/AOT.952503
Original article
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952888
Original article
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional ...Ann Transplant In Press; DOI: 10.12659/AOT.953598
Most Viewed Current Articles
24 Aug 2021 : Review article 21,160
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 17,335
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,325
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,249
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






